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Abstract.  One characteristic  of skeletal muscle 
differentiation is the conversion of proliferating cells to 
a population that is irreversibly postmitotic.  This de- 
velopmental change can be induced in vitro by depriv- 
ing the cultures of specific mitogens such as fibro- 
blast growth factor (FGF).  Analysis of cell surface FGF 
receptor (FGFR) in several adult mouse muscle cell 
lines and epidermal growth factor receptor (EGFR) in 
mouse MM14 cells reveals a correlation between re- 
ceptor loss and the acquisition of a postmitotic pheno- 
type. Quiescent MM14 cells, mitogen-depleted, differ- 
entiation-defective MM14 cells, and differentiated 
BC3H1 muscle cells (a line that fails to become post- 
mitotic upon differentiation) retained their cell surface 
FGFR.  These results indicate that FGFR loss is not 
associated with either reversible cessation of muscle 
cell proliferation or biochemical differentiation and 
thus,  further support a correlation between receptor 
loss and acquisition of a postmitotic phenotype.  Com- 
parison of the kinetics for growth factor receptor loss 
and for commitment of MM14 cells to a postmitotic 
phenotype reveals that FGFR rises transiently  from 
m700 receptors/cell to a maximum of *  2,000 recep- 
tors/cell  12 h after FGF removal,  when at the same 
time,  >95%  of the cells are postmitotic.  FGFR levels 
then decline to undetectable levels by 24 h after FGF 
removal.  During the interval  in which FGFR increases 
and then disappears there is no change in its affinity  for 
FGE  The transient  increase in growth factor receptors 
appears to be due to a decrease in ligand-mediated  in- 
ternalization  because EGFR, which undergoes an im- 
mediate decline when cultures are deprived of FGF 
(Lim,  R. W.,  and S.  D.  Hauschka.  1984. J.  Cell Biol. 
98:739-747),  exhibits a  similar transient rise when cul- 
tures are grown in media containing both EGF and 
FGF before switching the cells to media without these 
added factors. These results indicate that the loss of 
certain growth factor receptors is a  specific phenotype 
acquired during  skeletal muscle differentiation,  but 
they do not resolve whether regulation of FGFR num- 
ber is causal for initiation  of the postmitotic pheno- 
type. A  general model is presented in the discussion. 
a model system to study the loss of proliferative  ca- 
pacity that accompanies terminal  differentiation,  we 
investigated the mechanisms involved in the irrevers- 
ible conversion of proliferating  skeletal muscle myoblasts to 
a postmitotic  phenotype. This transition,  which occurs both 
in vivo (Snow, 1977, 1978) and in culture (Konigsberg,  1975; 
Nadal-Ginard,  1978; Hsu et al.,  1979),  is known to be in- 
fluenced by components in the growth medium (Yaffe et al., 
1971; Konigsberg,  1971). Impure  fibroblast  growth  factor 
(FGF) t preparations,  for instance,  were shown to promote 
mouse and  bovine myoblast proliferation,  and  to  repress 
1.  Abbreviations  used  in  this  paper:  aFGF and bFGE  acidic and basic 
fibroblast growth factors,  respectively;  DM,  deficient  medium (includes 
Ham's  F-10C plus 5%  horse serum and  1 IJ,  M  insulin; EGF,  epidermal 
growth factor;  EGFR, epidermal growth factor receptor; FGE fibroblast 
growth factor;  FGFR,  fibroblast growth  factor  receptor;  FM,  complete 
medium (includes  Ham's F-10C plus 15% horse serum); HS, horse serum; 
MHC, myosin heavy chain; TGF-13, transforming growth factor-13. 
skeletal  muscle  terminal  differentiation  (Linkhart  et  al., 
1980, 1981; Gospodarowicz et al., 1976). More recently, we 
have shown in mouse MM14 myoblasts  that pure prepara- 
tions  of both  acidic  and  basic  fibroblast  growth  factors 
(aFGF and bFGF, respectively) repress the onset of skeletal 
muscle differentiation,  thereby preventing the acquisition  of 
a permanent postmitotic phenotype, transcriptional  induc- 
tion of skeletal muscle specific genes, and cell fusion (Clegg 
et al.,  1987).  FGF-dependent repression of myogenic  dif- 
ferentiation  is  not  limited  to murine  skeletal  muscle cell 
lines.  Primary  human  skeletal  muscle  myoblasts  exhibit 
FGF-dependent and FGF-independent colony forming types 
(Hauschka, S. D., and J. Seed, unpublished data). Although 
the FGF-independent clones do not require added FGF for 
growth,  their  differentiation  is delayed in the presence of 
FGE  A  similar  response has  been observed for primary 
chick  skeletal  muscle myoblasts  (Kardami  et  al.,  1985a; 
Seed and Hauschka,  1988). 
© The Rockefeller University Press, 0021-9525/88/08/761/9  $2.00 
The Journal of Cell Biology, Volume 107, August 1988 761-769  761 Since our previous studies indicate that FGF plays an im- 
portant role in the regulation of skeletal muscle differentia- 
tion, and since terminal differentiation of MM14 cells is ac- 
companied by a permanent loss of epidermal growth factor 
receptor (EGFR) (Lim and Hauschka, 1984a),  we hypothe- 
sized  that the postmitotic phenotype is a  consequence of 
growth  factor receptor  loss.  This  model  was  speculative 
since  MM14  myoblasts do  not exhibit a  proliferative re- 
sponse to EGF even though they possess ,,o10,000 EGFR per 
cell. With the subsequent availability of J25I-aFGF and iden- 
tification of the  cross-linked  t25I-aFGF-fibroblast  growth 
factor receptor (FGFR) complex in MM14 cells (Olwin and 
Hauschka,  1986),  it became  feasible to  test the  mitogen 
receptor-loss model with respect to FGFR. 
In this report, we examine growth factor receptor behavior 
to determine how cell surface receptor levels change during 
the differentiation of skeletal and smooth muscle cell types; 
and to determine the temporal relationship between changes 
in FGFR and EGFR levels and the kinetics for acquisition 
ofa postmitotic phenotype in mitogen-depleted skeletal mus- 
cle cultures. 
Materials and Methods 
1issue Culture 
Murine MM14  cells (Hauschka et al.,  1979;  Linkhart et al.,  1981) and 
C2C12 cells (derived by Yaffe and Saxel,  1977; subcloned by Blau et al., 
1985; and kindly provided by Dr. A. Lassar, Hutchinson Cancer Research 
Center, Seattle, WA) were grown on gelatin-coated  culture dishes in Ham's 
F-10C (F-10 supplemented with 0.8 mM Ca2+), increasing concentrations 
of a mixture of aFGF and bFGF from 2-10 ng/ml as the culture density in- 
creased from 1-2  x  105-1 ×  106 cells per 100-ram dish,  1% antibiotics 
(10,000 U/ml penicillin G, 0.5 mg/ml streptomycin sulfate, 0.05 mg/ml gen- 
tamicin), and 15% horse serum (HS).  BC3H1-AI cells were re-subcloned 
by us from BC3HI cells (No.  1443;  American Type Culture Collection, 
Rockville,  MD) to yield a line with much more homogeneous differentia- 
tion. The cells were grown in DME containing 20% FCS and 4 ng/ml FGE 
Complete medium (FM) includes Ham's F-IOC plus 15% HS and deficient 
medium (DM) includes  Ham's F-10C plus 5% HS and 1 taM insulin (in- 
cluded to prevent myotube degeneration). 
Purification and Iodination of  aFGF 
These procedures were carded out as described (Oiwin and Hauschka, 
1986) with the following modification.  Heparin-Sepharose-purified aFGF 
was further purified to remove trace contaminants by FPLC on a mono-S 
column (Pharmacia, Inc., Piscataway, NJ) and eluted with a 0.1-1.0 M NaCl 
gradient in 20 mM Hepes,  pH 7.4. 
lodination of  EGF 
Receptor grade EGF (Sigma Chemical Co., St. Louis, MO) was incubated 
with 2.0 mCi Na J25I and 60 I.tg of chloramine T for 5 min at 22°C in 0.5 
M sodium phosphate,  pH 7.0. Sodium bisulfite (120 lag) was added at 5 min 
and the products were incubated an additional 5 min before separating  free 
125I from 125I-EGF by chromatography  on Sephadex  G-15 (preequilibrated 
in 20 mM  Hepes  pH  7.4,  150  mM  NaC1, and 0.2%  BSA).  IzSI-EGF 
specific activity  was ,x,l.4  x  106 dpm/pmol. 
Assays 
Postmitotic cells. Postmitotic cells were detected by their inability to form 
colonies when passaged and replated at low density (1,000 cells per 100-ram 
dish) in FM containing 6 ng/ml FGE Cells were grown for 4 d and the num- 
ber of macroscopic  colonies (eight or more cells) counted.  Percent commit- 
ment was defined as: 100 x  [1 -  (n macroscopic clones/n clones from con- 
trol plate before FGF removal)]. 
Myosin Heavy Chain (MHC). Cultures were  rinsed twice with PBS, 
fixed for 1 min (20:2:1,  70% ethanol/formalin/glacial acetic acid) at 4°C 
and stored in PBS at 4°C. MHC was detected by incubating plates with the 
MF-20 monoclonal antibody (Bader et al., 1982) diluted with 1% HS in 50 
mM Tris-Cl,  pH 7.4, 100 mM NaCI for 1 h. Plates were rinsed and stained 
using an avidin-biotin-horseradish  peroxidase procedure (Vector Laborato- 
ries,  Inc., Burlingame,  CA). 
Single Cell Autoradiography. Cultures were rinsed twice with Ham's 
F-10C containing 25 mM Hepes, pH 7.4 and incubated for 1 h with 100 pM 
~25I-aFGF in Ham's  F-10C containing 25  mM Hepes,  pH 7.4 and 0.2% 
BSA (binding buffer) for 1 h at 22°C,  rinsed four times with ice-cold PBS, 
and fixed with 2 % gluteraldehyde in PBS at 4°C for 2 min. The dishes were 
rinsed  10 times with glass-distilled  H20,  air dried,  coated  with Kodak 
NTB2 liquid emulsion, and exposed for 1-2 wk at 4°C. The plates were de- 
veloped  according to the manufacturer's  instructions. 
Binding and Cross-linking of u~I-aFGE The binding and cross-linking 
of ~251-aFGF to intact cell cultures was performed as described (Olwin and 
Hauschka,  1986). Briefly, for equilibrium binding,  intact cells were plated 
at 1 x  106 cells on 35-mm dishes and incubated for 2 h in FM with or with- 
out FGF. The cultures were rinsed twice in Ham's FIOC containing 25 mM 
Hepes,  pH 7.4 and 0.2%  BSA.  ~25I-aFGF was then added without or with 
a 100-fold M excess of aFGF to determine nonspecific binding and the cul- 
tures incubated on a rocker platform at-30 cycles/min  for 1 h at 22°C or 
3 h at lO°C. Cultures were then rinsed three times in PBS containing 2 mM 
MgCI2 and 0.2%  BSA, and the bound '25I-aFGF solubilized  in PBS con- 
raining  !% Triton X-100. 
Cross-linking of uSI-EGE 125I-EGF (8.0 nM) was incubated with intact 
MM14 cultures  for 1 h at 22°C  in binding buffer. The dishes were then 
rinsed three times with ice-cold PBS and incubated with 4 mM ethylene car- 
bodiimide (Pierce Chemical Co., Rockville, IL) in PBS (pH 6.5) for 30 min 
at 220C, rinsed twice with ice-cold PBS (pH 7.4), and processed  as previ- 
ously described for 12~I-aFGF-FGFR detection by SDS-PAGE and autora- 
diography  (Olwin and Hauschka,  1986). 
Results 
FGF Binding to Proliferating and Differentiated 
Muscle Cultures 
To detect cell surface FGFR on proliferating and differen- 
tiated muscle cells,  ~25I-aFGF binding sites were visualized 
using single cell autoradiography.  The results  indicate that 
proliferating skeletal muscle cells (MM14,  C2C12), as well 
as  smooth  muscle  cells  (BC3H1-A1)  exhibit  specific  FGF 
binding (Fig. 1, a, c, and e). In contrast, terminally differen- 
tiated  MM14  and  C2C12  cells exhibit a total  loss of FGF 
binding,  irrespective  of whether  they  are  mononucleated 
or multinucleated  (Fig.  1,  b and d),  whereas differentiated 
BC3H1-A1 cells, a brain tumor-derived smooth muscle cell 
line that does not become postmitotic upon differentiation 
(Schubert  et al.,  1974;  Lathrop  et al.,  1985a),  maintains 
high  levels of '2~I-aFGF binding  (Fig.  1 f).  Interestingly, 
Figure 1.  ~25I-aFGF binding to MM14, C2C12,  and BC3H1-A1 cells before and after differentiation. Proliferating myoblasts were cultured 
in FM plus 6 ng/ml FGF (MM14), DME plus 20% FCS and 6 ng/ml FGF (C2C12 and BC3HI-A1) for 48 h. Differentiated cultures were 
grown in the same medium for 48 h  then rinsed three times with saline G  and incubated in Ham's F-IOC containing 1 IxM insulin plus 
5%  HS,  DME plus  1% HS,  and DME plus 0.5%  FCS for MM14, C2C12,  and BC3H1-A1 cultures, respectively. Cultures were rinsed, 
incubated with  100  pM  t25I-aFGE  fixed,  and processed  for  autoradiography  as  described  in  Materials  and  Methods.  Differentiated 
MMI4, C2C12, and BC3HI-A1 cultures were maintained in their mitogen-poor medium for 24, 48 h, and 4 d, respectively. In this period 
after mitogen withdrawal, MMI4, C2C12, and BC3H1-A1 cells exhibited 100, 75, and 85 % MHC-positive cells, respectively. Photographs 
are bright field images of proliferating MM14, C2C12, and BC3H1-A1 (a, c, e, and e') and differentiated MM14, C2C12, and BC3HI-A1 
(b, d,  and f)  cultures,  respectively.  Bar,  30 I.tm. 
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MM14 myoblasts were grown 12 h in FM plus FGF then rinsed 
and switched to Ham's F-10C including 1% HS and 1 IxM insulin 
in the presence of 10 ng/ml FGF for 24 h. At this time one set of 
parallel cultures was incubated with 100 pM t2SI-aFGF for 1 h at 
22°C,  fixed, and processed for autoradiography as described  in 
Materials and Methods. The other was rinsed, incubated for 30 min 
with 3 IxCi/ml [3H]thymidine, fixed, and processed for MHC de- 
tection and autoradiography. Less than 8 and 15% of the cells were 
[3H]thymidine positive and MHC positive, respectively. By com- 
parison, proliferating MM14 cells are 60% [3H]thymidine  positive 
and  <1%  MHC  positive  while  differentiated  cells  are  <1% 
[SH]thymidine positive and >99%  MHC positive. Bar, 30 ~tm. 
the rat L6 skeletal muscle cell line does not exhibit t2SI-aFGF 
binding in either proliferating or differentiated cultures (not 
shown). 
FGFR Loss Is Specifically Associated with the 
Postmitotic Phenotype of  Skeletal Muscle Cells 
If FGFR loss is associated with the skeletal muscle postmi- 
totic phenotype and not simply with cessation of cell pro- 
liferation, then FGFR should be present in quiescent, myo- 
blast cultures. This could be examined in MM14 myoblasts 
that were maintained in low concentrations of HS and high 
concentrations of FGE Under these conditions MM14 cells 
withdraw from the cell cycle, but do not differentiate; they 
will  replicate once serum  is  restored,  demonstrating  that 
they have not committed to a permanent postmitotic pheno- 
type (Clegg et al.,  1987). When quiescent cultures were ex- 
amined for FGFR by single cell autoradiography (Fig. 2) or 
by cross-linking ~25I-aFGF to intact cells (not shown), they 
retained high levels of cell surface FGFR. However, if MM14 
cells were maintained for 24 h in 1 or 5 % HS without FGF 
they exhibited no detectable cell surface FGFR (Figs. 1 b and 
4; Table I). A similar total loss of FGF binding was exhibited 
by C2C12 cells when they were deprived of serum mitogens 
for >.>.48 h (Fig.  1, a and d). A further indication that FGFR 
loss is associated with the skeletal muscle postmitotic pheno- 
type is  seen from the behavior of differentiation-defective 
(DD-1) myoblasts (Lim and Hauschka, 1984b). This variant 
MM14 cell line behaves similarly to the parental MM14 cells 
by withdrawing from the cell cycle when both FGF and se- 
rum are depleted, but the cells do not become postmitotic 
and in addition, they do not lose their cell surface FGFR (Ta- 
ble I). Taken together, these results indicate that the loss of 
FGFR  is  associated  with  the  skeletal  muscle  postmitotic 
phenotype and is not simply a consequence of a muscle cell's 
proliferative state. 
Kinetic Analysis of  FGFR Behavior during 
MMI4 Terminal Differentiation 
To determine the  kinetics  of FGFR  loss  during  terminal 
differentiation, MM14 cell surface FGFR was analyzed by 
equilibrium binding (Fig.  3;  Table I) and by cross-linking 
tESI-aFGF to intact cells (Fig. 4).  After 24 h of FGF with- 
drawal  FGFR  was  undetectable;  however,  an  unexpected 
increase in FGFR was revealed during the first 12 h  after 
FGF removal. This result could represent a true increase in 
cell surface FGFR;  alternatively it could be due to an in- 
creased affinity of the receptor for FGE or to an artifact due 
to unlabeled FGF remaining after the switch to FGF-defi- 
cient medium;  such residual FGF would be gradually de- 
graded, but would initially dilute the n2SI-aFGF specific ac- 
tivity. The latter two alternatives appear to be eliminated by 
the following observations. First, analysis of the equilibrium 
binding data reveals no significant change in the Ko for n2sI- 
Table L FGFR  Behavior in MM14 and MM14 DD-1 Cells 
FGF deprivation*  Cell type*  Ko§  FGFR per cell§ 
h  pM 
0  MM14  8  +  3  700  +  25011  (3) 
12  MM14  7  ±  1  2,000  4-  500  (3) 
24  MM 14  nm¶  01  (4) 
0  MM14  DD-1  12  10,500  (2) 
24  MM14 DD-1  11  12,000  (2) 
60  MM14  DD-1  11  9,000  (2) 
* Cells were maintained in FM plus 10 ng/ml FGF. FGF was removed by rinsing three times with Puck's Saline G and cells were incubated in DM for the times 
indicated before equilibrium 12SI-aFGF binding. 
* MMl4 DD-1  cells are a nondifferentiating MMl4 variant that does not require FGF for proliferation (Lim and Hauschka, 1984b). 
§ Data for Kd and FGFR number per cell  were obtained by Scatchard analysis of equilibrium binding data. 
II Mean and standard deviation. Numbers in parentheses refer to number of independent experimental determinations. Where two determinations were performed 
the mean is reported. 
ql Not measurable (values for specific  and nonspecific ~251-aFGF binding were equal). 
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Figure 3. Equilibrium  binding 
of ~25I-aFGF  to intact differen- 
tiating MM14 cultures.  MMI4 
myoblasts were grown in FM 
plus FGF (n) or in FM with- 
out FGF for 7 (e),  and  12 h 
(o).  Cultures were processed 
as described in Materials  and 
Methods.  The data were plot- 
ted according to Scatchard and 
normalized  to  1  x  106 cells. 
On average 5  x  105 cells  were on each 35-mm dish and the non- 
specific binding did not exceed 20% of the total bound cpm at satu- 
ration. The data plotted are the mean of triplicate points from parallel 
cultures of a single  experiment. 
aFGF binding during FGF deprivation (Fig. 3 and Table I). 
Second, an independent analysis of the rinsing procedure in- 
dicates that 3,98 % of  the FGF initially present is removed be- 
fore the addition of t:5I-aFGE The residual  low concentra- 
tion of unlabeled  PGF  (<5  pM)  is  insufficient to compete 
significantly for binding of 100 pM  125I-aFGF to intact cells 
(Olwin  and  Hauschka,  1986).  Third,  cross-linking  MM14 
cells with fivefold higher concentrations of t25I-aFGF (500 
pM) also revealed the transient two- to threefold increase in 
FGFR during the first 12 h of FGF withdrawal. The transient 
rise in FGFR before FGFR declines seems most readily ex- 
plained by a cessation of rapid ligand-induced internalization 
Figure 5.  Cross-linking  of 125I-EGF to differentiating  MM14 cul- 
tures.  MM14 cultures  were grown in FM plus FGF and 100 ng/ml 
EGF then switched to DM for the various times indicated and ana- 
lyzed by SDS-PAGE and autoradiography as described in Materi- 
als and Methods.  1  x  l06 cells  were cross-linked and the entire 
samples were run in each lane of the SDS-polyacrylamide gel. The 
~25I-EGF-EGFR complex migrated at  175 kD and the uppermost 
bands represent higher order cross-linked material that did not enter 
the SDS-polyacrylamide gel.  The experiment was repeated  twice 
with  similar  results. 
Figure 4. Cross-linking of 125I-aFGF to differentiating  MMI4 cul- 
tures.  MMI4 cultures  were grown in FM plus FGF or DM for the 
various times indicated.  Cultures were then rinsed  and incubated 
with  125I-aFGF as  described  in  Materials  and  Methods.  Cross- 
linking,  SDS-PAGE,  and autoradiography were performed as de- 
scribed (Olwin and Hauschka,  1986).  The film was exposed for 
14 d at -70°C with a DuPont Cronex Intensifying Screen.  The con- 
trol  lane  (C)  included  10  nM  unlabeled  aFGF  during  the  ~25I- 
aFGF-incubation period.  The uppermost bands  represent  higher 
order cross-linked material  that did not enter the 7.5% SDS-poly- 
acrylamide gel. The entire samples from identical numbers of cells 
(1  x  106) were run  in each  lane.  The experiment was  repeated 
three times  with similar  results. 
upon FGF withdrawal while an existing pool of intracellular 
FGFR is continually inserted into the plasma membrane (see 
below). 
Analysis of  EGFR Behavior during 
MM14 Terminal Differentiation 
MM14 cells exhibit cell surface EGFR but do not respond 
mitogenically  to  EGE  Whether  EGF  has  other  effects on 
skeletal muscle cells is not known. In previous studies EGFR 
was examined in FGF-deprived, MM14 cultures as a model 
for growth factor receptor behavior during muscle differenti- 
ation  (Lim and Hauschka,  1984a).  Initial experiments  ex- 
amining  EGFR  loss during  skeletal  muscle  differentiation 
suggested that a general loss of mitogen receptors might be 
a  causal event for commitment to a  postmitotic phenotype 
(Lim and  Hauschka,  1984a).  We have  reexamined  EGFR 
decline to determine whether the kinetics of its loss are con- 
sistent with a common EGFR and FGFR regulatory mecha- 
nism.  In  contrast  to  the  earlier  experimental  protocol  in 
which EGFR was measured in cultures that had not been ex- 
posed to EGF-containing medium before FGF removal, both 
EGF and FGF were included in the initial  growth medium 
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like FGFR,  would be subjected to the absence of ligand- 
mediated internalization,  thus allowing a more direct com- 
parison of EGFR and FGFR behavior in FGF-deprived cul- 
tures (Fig. 4). Analysis of EGFR by cross-linking I25I-EGF 
to intact MM14 cells at various times after EGF and FGF 
removal indicated both a transient increase and then a com- 
plete  loss  of EGFR,  similar  to  that  observed  for  FGFR 
(Fig.  5). 
Kinetic Analysis of  FGFR Loss versus the Kinetics of 
Commitment to a Postmitotic Phenotype 
If FGFR loss is the causal event for irreversible acquisition 
("commitment") of growth  factor nonresponsiveness,  then 
FGFR decline should either precede or parallel the kinetics 
of commitment to a postmitotic phenotype. In this experi- 
ment postmotitic cells were detected by their failure to form 
colonies  when  replated in FM  including  6  ng/ml  FGF  at 
various times after FGF deprivation. A comparison of the ki- 
netics for acquisition of a postmitotic phenotype and cell sur- 
face receptor loss (Figs.  3 and 4) in parallel cultures indi- 
cated that commitment to a postmitotic phenotype exceeds 
50% 6 h after FGF removal, while the cell surface FGFR level 
has increased two- to threefold during the same interval (Fig. 
6). At 12 h, when virtually all the cells have committed to 
a postmitotic phenotypc, the cell surface FGFR level is still 
elevated; it does not decline until sometime after 12 h, be- 
coming undetectable by 24 h. Similar FGFR behavior is ob- 
served  whether  the  receptor  quantitation  is  by  chemical 
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Figure 6.  Comparison of the kinetics of FGFR loss and commit- 
ment to a postmitotic phenotype. The percent relative FGFR was 
determined  from  both  cross-linked  i25I-aFGF and  equilibrium 
binding experiments and is compared with the percent cells com- 
mitted to a postmitotic phenotype after the same intervals of FGF 
deprivation.  Cross-linked  125I-aFGF-FGFR (e)  was determined 
from a densitometric  scan of the autoradiogram  in Fig. 4, where 
100% was the initial value of the ]2~I-aFGF-FGFR complex at the 
time of FGF removal. Equilibrium  binding values for FGFR (0) 
were determined from the data in Fig. 3, where 100% was the initial 
FGFR number per cell at the time of FGF removal. Percent com- 
mitment (n) was determined in parallel cultures by passaging cells 
at the indicated times after FGF withdrawal, replating the cells at 
low density (1,000 per 100-mm dish) and incubating in FM plus 10 
ng/ml FGF for 4 d. The cultures were stained with hematoxylin, 
macroscopic cell colonies scored,  and expressed as percent com- 
mitment where 0% commitment at time 0 corresponds to 426 colo- 
nies and 99% commitment at 24 h corresponds  to four colonies. 
MM14 cells that have committed to a postmitotic phenotype do not 
proliferate,  stain MHC positive as single differentiated cells, and 
thus are not scored as macroscopic colonies. Each point represents 
the average percent commitment from duplicate dishes. 
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Figure 7. FGFR behavior and 
myosin  accumulation  during 
BC3H1-AI cell differentiation. 
BC3H1-AI cells were grown in 
DME plus 20% FCS for 24 h, 
rinsed three times with Puck's 
Saline  G,  and  switched  to 
DME plus 0.5% FCS for 4 d. 
On each day the FGFR num- 
ber per cell was determined by 
equilibrium  binding with 200 pM ~25I-aFGF in the presence and 
absence of 20 nM aFGE The cells were processed  for t~I-aFGF 
binding as described in Materials  and Methods.  Parallel cultures 
were fixed, stained for MHC (Materials and Methods), and scored 
for the percent MHC-positive cells relative to the total cell number 
present. The data points represent mean values from triplicate de- 
terminations.  This  experiment  was  repeated  twice  with  similar 
results. 
cross-linking or by equilibrium binding.  From these results 
the cell surface FGFR levels detected during the first 12 h 
after FGF deprivation cannot be directly implicated as caus- 
ing the postmitotic phenotyp¢ (see Discussion).  However, 
since cell surface FGFR is absent by 24 h, this could be im- 
plicated as the primary mechanism responsible for main- 
tenance of differentiated muscle cells in a postmitotic state. 
Analysis of  FGFR Behavior during BC3H1-A1 Muscle 
Cell Differentiation 
To further investigate the relationship between FGFR loss 
and the postmitotic phenotype, FGFR behavior was studied 
during differentiation of the BC3H1-A1  smooth muscle cell 
line.  Upon differentiation, BC3H1 cells undergo transcrip- 
tional induction  of muscle-specific genes,  but they do not 
fuse nor commit to a postmitotic phenotyp¢ (Schubert et al., 
1974;  Lathrop et al.,  1985a,  b).  These cells also exhibit 
FGF-mediated  repression  of  muscle  cell  differentiation 
(Lathrop et al.,  1985a, b). BC3H1 cells thus offer a system 
for studying FGFR behavior in differentiating muscle cells 
that do not become postmitotic. When switched from me- 
dium containing 20% FCS to 0.5 % FCS, BC3H1-A1 cells un- 
dergo a  gradual increase in the  number of MHC-positive 
cells. At 4 d, when 75 % of the cells were MHC positive and 
not replicating, there was no change in the apparent FGFR 
number per cell (Fig.  7).  Scatchard analysis of I25I-aFGF 
equilibrium binding data to BC3H1-A1  cells confirmed this 
result,  revealing no change in either the Kd for ~25I-aFGF 
binding or the FGFR number per cell (Table II). 
Although the equilibrium binding data could not distin- 
Table II. 1251-aFGF  Binding to BC3H1-A1 Ceils 
Proliferative state*  Kd*  FGFR per cell 
pM 
Proliferating  15  ±  9  7,500 ±  2,000 
Differentiated  14  ±  3  7,000  ±  1,500 
* Cells were grown in DME and 20% FCS (proliferating) or 0.5% FCS (dif- 
ferentiated) for 4 d. Percent MHC positive cells were <1 and 75 %, respectively. 
* The data for Kd and FGFR number per cell were determined by Scatchard 
analysis of equilibrium ~2SI-aFGF binding data. Mean and standard deviation 
from three independent experiments are reported. 
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tiated BC3H1-A1 cultures was solely attributable to the 25 % 
fraction of the cell population that failed to express MHC, 
this  possibility was  eliminated by  single  cell  analysis of 
125I-aFGF binding (Fig. I f) showing uniform labeling over 
all cells in the culture. The failure of differentiated BC3H1- 
A1 cells to lose their FGFR thus appears to correlate with 
their failure to acquire a postmitotic phenotype. 
Discussion 
Terminal differentiation of skeletal muscle in culture is ac- 
companied by a complete and permanent loss of cell surface 
FGF and EGF binding (Figs.  1 and 5). The loss of growth 
factor binding most likely represents a true loss of receptors 
from the cell surface, since for FGFR, the loss of binding 
capacity is not due to changes in FGF affinity (Fig. 3). Fur- 
thermore, since MMI4 cells lose both EGFR and FGFR with 
a nearly identical time course (Figs. 4 and 5), it is also un- 
likely that FGFR loss is due to secretion of a soluble factor 
that competes for FGF binding. This conclusion is also sup- 
ported by the fact that 16 h after FGF removal, FGFR- and 
EGFR-positive cells can be observed adjacent to mononu- 
cleated cells and myotubes that fail to bind to either growth 
factor (Lim and Hauschka, 1984a; Olwin, B. B., and S. D. 
Hauschka, data not shown). By 24 h FGFR appears to be lost 
not only from the cell surface but also appears to be elimi- 
nated from the entire cell because crude membrane prepara- 
tions from lysed cells exhibit no specific 125I-aFGF binding 
(data not shown). 
FGFR loss is not peculiar to a single myogenic cell line 
since  two  independently  derived  skeletal  muscle  lines 
(MM14 and C2C12), which acquire a postmitotic phenotype 
during terminal differentiation, undergo a permanent loss of 
cell surface FGFR. Although both cell lines are repressed 
from terminal differentiation by FGF and lose their FGFR 
when mitogens are removed, only MM14 myoblasts are ab- 
solutely dependent upon added FGF for replication. Thus, 
FGFR loss during skeletal muscle development is not depen- 
dent on whether FGF is  required  for proliferation.  That 
FGFR loss is associated with the postmitotic phenotype and 
not simply with the cessation of proliferation and the expres- 
sion of muscle-specific genes is evident from the behavior of 
BC3H1-AI cells. These cells become myosin positive in re- 
sponse to FGF and serum deprivation, but they do not lose 
their cell surface FGFR and do not become postmitotic. 
While our data indicate that FGFR and EGFR are lost 
from the cell surface of differentiated skeletal muscle cells, 
not all "growth factor" receptors exhibit this behavior. Insulin 
receptors  increase  severalfold during  L6  skeletal muscle 
differentiation while insulin-like growth factor (IGF) I and II 
receptors decrease severalfold, but do not disappear (Begui- 
not et al., 1985).  Thus, while some growth factor receptors 
may undergo a coordinate decrease, others are clearly regu- 
lated by independent processes. 
We  previously  observed  that  EGFR  loss  accompanies 
MM14 terminal differentiation and proposed that mitogen 
receptor loss may be a causal event for terminal skeletal mus- 
cle differentiation (Lim and Hauschka,  1984a).  However, 
since MM14 cells are not responsive to EGF, it was unclear 
whether the disappearance of EGFR would be an accurate 
indication of FGFR behavior during MM14 differentiation. 
These previous  observations have now been extended by 
demonstrating that the loss of EGFR and FGFR occur with 
nearly identical kinetics (Figs. 4 and 5). The transient rise 
in these cell surface receptors, an immediate consequence of 
growth factor removal, most likely results from a cessation 
of rapid, ligand-induced internalization. The decline in these 
receptors, which begins 12-16 h after FGF removal, is pre- 
sumably due to the cessation of EGFR and FGFR biosynthe- 
sis many hours earlier, followed by the subsequent depletion 
of the intracellular and cell surface receptor pools via an in- 
trinsic degradation process. The additional observation that 
MM14 cell surface EGFR expression is absolutely depen- 
dent on added FGF but not on EGF, and that removal of FGF 
in the continued presence of EGF results in loss of EGFR 
(unpublished data), suggests that FGFR and EGFR as well 
as other mitogen receptors could be developmentally regu- 
lated by a common mechanism during skeletal muscle differ- 
entiation.  Since transforming growth factor-I~ (TGF-13) is 
also a repressor of myogenic differentiation (Florini et al., 
1986;  Massagu6  et  al.,  1986;  Olson  et  al.,  1986),  our 
model predicts that a loss of TGF-13 receptors is likely to oc- 
cur during terminal differentiation of muscle cell lines such 
as C2C12 and L6 that are responsive to TGF-I3; and indeed 
this  has  been  recently  reported  for  both  lines,  whereas 
BC3H1 cells, as in our study of FGFR loss, exhibited only 
a minimal decline in TGF-fl receptors (Ewton et al., 1988). 
Our results demonstrate that the decline in cell surface 
FGFR lags behind the loss of FGF growth responsiveness by 
at least 8 h (Fig. 6), and thus an immediate loss of cell sur- 
face FGFR per se is unlikely to be the causal event for MM14 
commitment to a postmitotic phenotype. Furthermore, the 
cell surface FGFR level is actually two- to threefold higher 
in committed cells 12 h after FGF removal than in prolif- 
erating cultures. Even though FGF affinity for FGFR is un- 
changed during this period (Fig. 3; Table I), restoration of 
FGF does not induce proliferation. This apparent paradox 
could be explained by a model in which FGFR synthesis as 
well as that of other mitogen receptors is abruptly terminated 
when the skeletal muscle terminal differentiation process is 
initiated. Even though the cell surface FGFR level is elevated 
12 h post-FGF withdrawal, the residual FGFR stores may be 
insufficient to provide an adequate proliferation signal when 
FGF is restored. In support of this hypothesis are the obser- 
vations  that  quiescent  cells  require  a  sustained  (6--8 h) 
exposure to mitogens before they reenter S phase (Carpen- 
ter and Cohen,  1976; Aharanov et al.,  1978; Schechter et 
al.,  1978),  and that S phase entry of mitotically synchron- 
ized MM14 cells requires 6-8 h of continuous FGF expo- 
sure  (Linkhart, T.  A.,  and S.  D.  Hauschka, unpublished 
observations). 
Alternatively,  differentiating skeletal  muscle  cells  may 
first acquire a postmitotic phenotype due to the blocking of 
one or more intracellular mitogenic signals. This possibility 
has been investigated in L6E9 rat cells in which cultures 
containing extensive myotubes still exhibited induction of 
c-myc mRNA  in  response  to  serum  addition  (Endo  and 
Nadal-Ginard, 1986).  If the c-myc induction did indeed oc- 
cur in myotubes, and not in residual single cells that may 
have escaped elimination during a cytosine arabinoside treat- 
ment, then it is clear that at least some types of postmitotic 
muscle cells retain portions of  a putative mitogenic signalling 
pathway. 
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tigated with heterokaryon techniques (Clegg and Hauschka, 
1987). In these studies postmitotic myocytes were fused with 
GI myoblasts and the heterokaryons were then exposed to 
FGF-containing medium plus  [3H]thymidine to determine 
whether either or both nuclei exhibited DNA synthesis. In 
heterokaryons containing ratios of even three GI nuclei to 
one postmitotic nucleus the post-mitotic phenotype is domi- 
nant; such cells exhibited no DNA synthesis and lost their 
cell surface EGF receptors. These results are thus consistent 
with either a receptor loss model for the postmitotic cells 
state or with a model in which postmitotic cells contain one 
or more trans-acfing factors that block mitogen-mediated in- 
tracellular signals. 
The in vivo behavior of muscle satellite cells represents an 
intriguing aspect of the mitogen receptor control model we 
have proposed for skeletal muscle development. These cells, 
which may remain quiescent and undifferentiated for years 
in adult muscle, reside beneath the basement lamina and in 
direct  contact  with  the  fully differentiated muscle  fiber 
(Mauro, 1961; Schultz, 1976). Upon muscle injury the satel- 
lite cells are stimulated to undergo many rounds of replica- 
tion, followed by fusion to form new muscle fibers (Snow, 
1977;  1978). In vitro satellite cell growth (Bischoff, 1975; 
Konigsberg et al., 1975) can be stimulated by a factor from 
crushed skeletal muscle or by FGF, but the mitogenic effect 
of  both factors also requires the simultaneous presence of se- 
rum (Bischoff, 1986a, b). To conform with the skeletal mus- 
cle growth factor receptor control model, during their in vivo 
developmental origin, satellite cells must retain their FGFR 
while neighboring muscle cells lose their FGFR, acquire a 
post-mitotic phenotype, and fuse into adjacent myotubes. In 
this model, the satellite cell FGFR must remain occupied by 
FGF thereby repressing the onset of terminal differentiation 
while the cell is simultaneously deprived of one or more 
other factors required for its continuous replication. In such 
an environment the satellite cell could then remain quiescent 
and undifferentiated as does the MM14 satellite cell line in 
the presence of a high FGF-low serum environment (Fig. 2; 
Clegg et al., 1987).  Since FGF is present in adult and em- 
bryonic skeletal muscle (Kardami et al., 1985b; Seed et al., 
1988),  and since FGF may be localized in the extracellular 
matrix (Baird and Ling, 1987; Vlodavsky et al.,  1987),  the 
possibility of satellite cells being continually exposed to FGF 
in vivo seems plausible. Additional factors in serum, which 
appear to be required for satellite cell proliferation, would 
presumably be accessible only upon muscle fiber injury. In 
the presence of FGF the serum factors would then promote 
satellite cell proliferation and fiber regeneration. 
The permanent loss of certain growth factor receptors, 
which we have reported in this and earlier studies (Lim and 
Hauschka, 1984a), could be an in vivo control process for 
maintaining the  terminally differentiated state  in  skeletal 
muscle as well as a general regulatory mechanism for the se- 
quential development of  other tissues (e.g., neurons). By los- 
ing specific receptors  at a  particular developmental stage 
cells would be  prevented from continued replication and 
from "reversing" their developmental pathways since they 
would then be unresponsive to the factors that control the 
growth and differentiation of their immediate precursors. 
Such a  regulatory system has the advantage of permitting 
some cells to cease replicating and to express differentiated 
functions at an early developmental time while other cells of 
the same type remain proliferative and expand the tissues to- 
tal cell mass. If  this model is pertinent to tissue development, 
critical mechanistic questions remain as to  the  nature of 
the microenvironment and/or cellular differences that are re- 
sponsible for generating such temporal diversity in cell be- 
havior,  and  how  the  expression  of  specific  receptors  is 
regulated. 
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